IP Library Granted Patent US 7,740,880
Granted Patent B2
US 7,740,880 · App. 11/367,228 · Granted Jun 22, 2010

Polymeric carrier for delivery of small interfering RNA

Assignee: University of Utah Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,740,880
App. No.
11/367,228
Granted
Jun 22, 2010
Kind
B2
Abstract

A carrier for delivering small interfering RNA (siRNA) into cells includes a cholesterol residue covalently bonded to oligoarginine. Mixing the siRNA with the carrier produces a complex-containing composition. Contacting a cell with the complex-containing composition results in delivery of the siRNA into the cell. Delivery of an siRNA targeted to vascular endothelial growth factor is a treatment for cancer. Methods of making the carrier and complex are also disclosed.

Claims (13)

1. A method of making a complex, the method comprising mixing a small interfering RNA with a conjugate comprising a cholesterol residue covalently bonded to oligoarginine through a formate residue linker, thereby forming the complex, wherein the conjugate is represented by the formula:

wherein n is about 4 to 16.

2. The method of claim 1 wherein the small interfering RNA is targeted to vascular endothelial growth factor.

3. The method of claim 2 wherein the small interfering RNA comprises siVEGF (SEQ ID NO:1 and SEQ ID NO:2).

4. The method of claim 1 wherein the oligoarginine comprises arginine residues, each of which is in the D form.

5. A composition comprising a mixture of a small interfering RNA and a conjugate comprising a cholesterol residue covalently bonded to oligoarginine through a formate residue linker, wherein the conjugate is represented by the formula:

wherein n is about 4 to 16.

6. The composition of claim 5 wherein the arginine residues are in the D form.

7. The composition of claim 5 wherein the small interfering RNA is targeted to vascular endothelial growth factor.

8. The composition of claim 5 wherein the mixture comprises a complex of the small interfering RNA and the conjugate.

9. The composition of claim 5 wherein n is about 9.

10. The method of claim 1 wherein n is about 9.

11. The composition of claim 7 wherein the small interfering RNA comprises siVEGF (SEQ ID NO:1 and SEQ ID NO:2).

Assignments (6)
CONFIRMATORY LICENSE Recorded May 12, 2015
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035636/0142 →
CONFIRMATORY LICENSE Recorded Nov 3, 2014
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034117/0055 →
CONFIRMATORY LICENSE Recorded Nov 3, 2014
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034117/0254 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jul 23, 2008
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021282/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2006
From: UNIVERSITY OF UTAH
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 017650/0455 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2006
From: KIM, WON JONG; KIM, SUNG WAN
To: UNIVERSITY OF UTAH
Reel/Frame 017650/0601 →
Continuity (1)
Related Publication 20070207966A1 · Sep 6, 2007